Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Farmmi (FAMI) Cash & Current Investments (2017 - 2025)

Farmmi filings provide 9 years of Cash & Current Investments readings, the most recent being $804098.0 for Q3 2025.

  • On a quarterly basis, Cash & Current Investments rose 65.27% to $804098.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $804098.0, a 65.27% increase, with the full-year FY2025 number at $804098.0, up 65.27% from a year prior.
  • Cash & Current Investments hit $804098.0 in Q3 2025 for Farmmi, down from $890336.0 in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $69.4 million in Q1 2023 to a low of $486522.0 in Q3 2024.
  • Median Cash & Current Investments over the past 5 years was $14.1 million (2022), compared with a mean of $21.7 million.
  • Biggest five-year swings in Cash & Current Investments: skyrocketed 2636.62% in 2021 and later crashed 98.38% in 2024.
  • Farmmi's Cash & Current Investments stood at $59.3 million in 2021, then crashed by 30.51% to $41.2 million in 2022, then plummeted by 68.94% to $12.8 million in 2023, then crashed by 96.2% to $486522.0 in 2024, then soared by 65.27% to $804098.0 in 2025.
  • The last three reported values for Cash & Current Investments were $804098.0 (Q3 2025), $890336.0 (Q1 2025), and $486522.0 (Q3 2024) per Business Quant data.